Back to Blog

Prevention and policy: hoping for a gathering storm and not a storm in a teacup

Tuesday 30th May 2023 - GMT

18 months out from a Westminster election (at most) we are hearing about prevention again, most recently in a wide-ranging speech from Sir Keir Starmer on the health mission of the Labour party. There are three ways to read this, through the eyes of an optimist, a pessimist or a realist. I’ll leave it to you to judge which I am, but below I set out some of the context and ideas that might mean it’s different this time.

At national level the current government consulted on Advancing our health: prevention in the 2020sand has not followed it up. It has commissioned independent reviews, notably the Khan review on tobacco, which made a radical recommendation on prevention: to turn off the tap of new smokers at source, and you can’t get much more preventive than that. There has been no direct response, although the government has announced new policies on e-cigarettes. Government has however signalled that the upcoming major conditions strategy will have a preventive component, mostly focused on secondary prevention, preventing deterioration once people have conditions and diseases. More broadly the levelling up health mission remains with its laudable aim of improving healthy life expectancy and narrowing health inequalities, albeit without a clear and coherent vehicle to achieve it, given the demise of the Health Disparities White Paper announced by Sajid Javid. The government has made some spending commitments, notably on preventing the harms of illegal drugs and in the early years. In the meantime, critical budgets such as those for public health, remain anaemic at best, losing a cumulative £3 billion of purchasing power against the real terms highpoint in 2015/16.

Beyond current national policy there is hope in integrated care systems (ICSs), now on a legal footing, if they are to meet their potential and not become another way to manage stretched NHS services. ICSs are still developing and growing pains are evident but they have immense potential to help stitch together the leadership, resources and intent needed to take a more preventive approach below the national level. The leaders that I talk to in and around ICSs are committed to shifting towards a more preventive system making the best use of data, expertise and knowledge of all those who have it, including communities themselves. The government-commissioned review carried out by Patricia Hewitt on the future of ICSs had a strong emphasis on this, but currently it sits alongside a list of other reviews awaiting a clear government response. ICSs are also consumed with other issues including reducing management costs and balancing system budgets, and these mustn’t be allowed to derail the bandwidth to fulfil their potential on prevention and population health.

There is hope in the emerging policy debate coming through the think-tank community and others, most importantly from beyond the usual health suspects. There have been a recent slew of reports and thinking and more to come from Demos, Institute for Public Policy Research, the Tony Blair Institute For Global Change, the Centre for Progressive Policy and Reform to name but a few. While the emphasis for each organisation is different, there is high concordance on the health and the broader economic case for change, especially the realisation that a society with avoidable poor health is one with avoidable poor productivity. There is also much agreement on where the focus needs to be, and just as critically how to get there, including investment in communities themselves; stronger incentives for prevention in the health and care system and leveraging the power and innovation of technology business while regulating its excesses; and a cross-government governance structure that finally breaks through short-termism, silo-thinking and results in action. None of these ideas are new but the overall coherence and concordance of the policy proposals from voices beyond the usual suspects, and beyond the confines of the health and care policy world, is new.

There is hope in efforts behind the political scenes, and in the cross-party machinery of scrutiny including the Health and Social Care Committee’s inquiry into prevention, keeping the debate and focus on why we as a nation are so poor at finding the collective will and mechanisms to do what everyone knows is right. And finally, there is hope in politicians and the political process itself. This last point will determine whether this time the rhetoric on prevention really is a coming storm, or a just another storm in a teacup.

Back to Blog
Prevention and policy: hoping for a gathering storm and not a storm in a teacup

We work with more than 200 leading Life Sciences companies including:

Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.

Paul Runeckles, Director of Execution Excellence


Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.

Simon Warden, National Sales Manager

Frontier Medical Group

I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.

Richard Edmonds

Gedeon Richter Women's Health

The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.

Robb Sayers, UK Capability Lead

ViiV Healthcare